| |
|
|
|
Altimmune Inc.  
|
|
1.55 0.02 (0.01%) |
11-20 16:00 |
|
Open: |
1.54 |
Pre close: |
1.53 |
Target:
|
2.15 
|
|
High: |
1.6101 |
Low: |
1.53 |
Resistance:
|
1.84
2.04
|
|
Volume: |
148,417 |
Market Cap: |
24M |
Support:
|
1.51
1.26
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.57
|
MACD |
MACD(12,26):
|
-0.11 |
|
MA(20): |
1.82 |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
2.09 |
Stochastic Oscillator |
%K(14,3):
|
6.79 |
|
MA(250): |
2.51 |
%D(3): |
10.28 |
|
Average Volume(K) |
3-Month: |
10695
|
52-Week |
High:
|
5.94 |
|
10-Days: |
17271 |
Low: |
1.51 |
|
RSI |
RSI(14):
|
21.71  |
Change(%): |
-53.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.161 |
Return on Equity (ttm) |
-69.9 |
Shares Out. (M) |
15.34 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-13.4 |
Shares Float (M) |
11.67 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
14.29 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-32.7 |
% Held by Institutions |
1.67 |
|
Forward EPS |
-2.032 |
Gross Profit (p.s.) |
-0.530 |
Shares Short (K) |
831 |
|
Book Value (p.s.) |
4.280 |
EBITDA (p.s.) |
-0.769 |
P/E |
-0.37 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.36 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.35 |
P/S |
1.27 |
|
Operating Margin |
-124.58 |
Levered Free Cash Flow
(M) |
-5.97 |
P/CF |
-2.09 |
|
|
|
|
|
|
